There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...

Almost every aspect of the COVID-19 response, from vaccines, diagnostics, and therapeutics to medical equipment, tracking systems, software, and other innovations, are or will become subject to some form of exclusive rights. Many of these involve intellectual property rights (IPRs). By offering...

This evaluation concerns the implementation of Regulation (EU) No 386/2012 on entrusting the European Union Intellectual Property Office (EUIPO) (former OHIM) with tasks related to the enforcement of intellectual property rights (IPRs), including assembling public- and private-sector...

It is widely regarded that the infringement of IP rights - and here most notably counterfeiting and piracy - is a problem which results in reduced revenues for IP right holders and preventing them from recuperating investments, for example, into R&D. Counterfeiting and piracy are said to...

The study study aims to provide "Support for an ex-post evaluation of Directive 2004/48/EC [IPRED] and for an Impact Assessment in view of legislative proposals modernising the enforcement of IPR". IPRED has been implemented between 2005-2009. A first, early evaluation (2011) could not establish...

This patents & licensing study provides a broad overview of the most recent patterns of technological specialisation at the level of European countries and other parts of the world. The analysis used a set of patent-based indicators, a survey on licensing behaviour of European firms and...